Effects of phosphonoformic acid and 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on distribution of tetracycline in the developing rat molar.
Tetracycline was used as a marker to study the effect of phosphonoformic acid and 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on the mineralization of the developing dental hard tissues. Groups of young rats were given a single subcutaneous injection of tetracycline and at the same time were injected with a single dose of either phosphonoformic acid or HEBP (10 mg P/kg b.w.). Alternatively, rats were injected with the tetracycline after different time intervals from the phosphonate injection. Rats were sacrificed at intervals ranging from 1 to 4 days. Frozen-sections were obtained at the level of the maxillary first molar and prepared for light and fluorescence microscopy. The results of the present study indicate that the distribution pattern of tetracycline in the developing dental hard tissues is greatly affected by the pathologic changes induced by phosphonoformic acid and HEBP. Both drugs caused similar changes in the pattern of tetracycline uptake in the developing enamel. There seems to be a direct relation between the presence of developmental defects of enamel and the degree of discoloration induced by tetracycline. Aberrations in the mineralization of dentin were caused only by HEBP. As demonstrated by this study, HEBP is capable of inducing a provisional inhibitory effect on dentin mineralization.
Fouda
N
N
Department of Oral Pathology, School of Dentistry, Karolinska Institutet, Huddinge, Sweden.
Kut
I A
IA
Hammarström
L
L
D000565:Ameloblasts / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D000818:Animals; D003560:Cysts / Q000139:chemically induced / Q000473:pathology; D003743:Dental Enamel / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D003744:Dental Enamel Hypoplasia / Q000139:chemically induced / Q000473:pathology; D003804:Dentin / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D004658:Enamel Organ / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D012968:Etidronic Acid / Q000494:pharmacology*; D005260:Female; D017245:Foscarnet / Q000494:pharmacology*; D008297:Male; D008963:Molar; D009805:Odontogenesis / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013752:Tetracycline / Q000008:administration & dosage / Q000493:pharmacokinetics*; D013997:Time Factors; D014070:Tooth / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology* / Q000502:physiology; D014074:Tooth Calcification / Q000187:drug effects
D017245:Foscarnet; D013752:Tetracycline; D012968:Etidronic Acid